Astron Pulsar

Vascular Intervention // Peripheral
Self-Expanding Stent System/0.018”/OTW

Astron Pulsar


     155 μm thin struts

     4F low profile

     Simple stent deployment






155 μm thin struts - thinner than the leading brands1

 

 


Thinner struts for low Chronic Outward Force (COF)2





 

 

 

 

 


Thinner struts and lower COF make a difference:*

 

 

 

  • Lower risk of restenosis3
  • Reduced vessel injury and inflammation4
  • Faster endothelialization5

*As demonstrated in pre-clinical studies



1mm stent oversizing at 90 days 6




4F Low Profile - Improved acute outcomes vs. 6F7

 

 


Potential for safer, faster and simpler procedures than 6F

 

 

  • Clinically proven lower access site complication rates7
  • Shorter compression time8
  • 45% smaller puncture site area than 6F9
  • No need for a closure device

 


 


Simple stent deployment7


 

 


 

 

Astron Pulsar

Indicated for use in patients with atherosclerotic disease of the femoral and infrapopliteal arteries and for the treatment of insufficient results after percutaneous transluminal angioplasty (PTA).*

Technical Data

Astron Pulsar Stent
Catheter type
OTW
Recommended guide wire
0.018"
Stent material
Nitinol
Strut thickness
155 μm
Stent coating
proBIO (Amorphous Silicon Carbide)
Stent markers
6 gold markers on each end
Sizes
ø 4 - 7 mm; L: 20 - 80 mm
Proximal shaft
3.6 F, hydrophobic coating
Usable length
70 cm (ø 5.0 - 7.0 mm)
72 cm (ø 4.0 mm, L: 60 - 80 mm)
75 cm (ø 4.0 mm, L: 20 - 40 mm)
120 cm (ø 5.0 - 7.0 mm)
130 cm (ø 4.0 mm, L: 60 - 80 mm)
135 cm (ø 4.0 mm, L: 20 - 40 mm)

Ordering Information

4.0 (4F) 358939358940358941359347359680
5.0 (4F)349267349268349269349270358942
6.0 (4F)349275349276349277349278358943
7.0 (4F)-349283349284349285349286
4.0 (4F)358944358945358946359346359681
5.0 (4F)349271349272349273349274358947
6.0 (4F)349279349280349281349282358948
7.0 (4F)-349287349288349289349290

Contact

contact
Country/Region

1 6.0 mm diameters; BIOTRONIK data on file;

2 6.0 mm diameters. Supera stent not possible to test due to its design and applied test method. BIOTRONIK data on file;

3 As demonstrated in pre-clinical studies: Zhao HQ, Nikanorov A, Virmani R, Jones R, Schwartz LB. Late stent expansion and neointimal proliferation of oversized nitinol stents in peripheral arteries. Cardiovasc. Intervent. Radiol. 2009 Jul; 32(4); 720-6;

4 As demonstrated in pre-clinical studies: Zhao HQ, Nikanorov A, Virmani R, Jones R, Schwartz LB. Late stent expansion and neointimal proliferation of oversized nitinol stents in peripheral arteries. Cardiovasc. Intervent. Radiol. 2009 Jul; 32(4); 720-6;

5 As demonstrated in pre-clinical studies: Konstantinos C. Role of endothelial shear stress in stent restenosis and thrombosis. JACC 2012.; Koppara et al. Circ Cardiovasc Interv 2015; 8: e002427.; EuroIntervention. BIOTRONIK data on file. 2010 Nov;6(5):630-7; Soucy N, Feygin J et al.;

6 Funovic M. Presented at LINC 2017;

7 Bosiers M, et al. 4-French-compatible endovascular material is safe & effective in the treatment of femoropopliteal occlusive disease: Results of the 4EVER Trial. J ENDOVASC THER. 2013; 20: 746-756;

8 Bosiers M, et al. 4-French-compatible endovascular material is safe & effective in the treatment of femoropopliteal occlusive disease: Results of the 4EVER Trial. J ENDOVASC THER. 2013; 20: 746-756;

9 BIOTRONIK data on file.

Leading competitors have been selected based on the PV Stent Revenue Market Shares EU, 2017 and PV Revenue Market Shares APAC 2015; (Source: Milennium Research Group Inc.). Latest SFA self expanding stents for each manufacturer; Supera is a registered trademark of the Abbott Group of Companies; Lifestent is a registered trademark of C.R. Bard; Zilver is a registered trademark of Cook Medical; EverFlex and Entrust are registered trademarks of the Medtronic Group of Companies; Innova is a registered trademark of Boston Scientific.

*Indication as per IFU.